At FDA's request, Type D Meeting expected in March 2026 to review Comparative Oncology biomarker data from patients treated in OST-HER2 Phase 2b human clinical trial and OST-HER2 trial in spontaneous ...

Request for FDA Rolling Review submitted to FDA on January 30, 2026 Non-Clinical and CMC BLA modules submitted to FDA At FDA's request, Type D Meeting expected in March 2026 to review Comparative ...

SlicerPETDenoise is a 3D Slicer extension that includes three modules intended for medical image research, particularly PET and CT image workflows. These modules assist in denoising, comparing, and ...

Moreover, we discuss strategies for metadata selection and human evaluation to ensure the quality and effectiveness of ITDs. By integrating these elements, this tutorial provides a structured ...

Questions? Learn more about RF Study Card Programs by contacting rfstudycardprogram@buffalo.edu and about card programs by contacting ubscardprograms@buffalo.edu. Contact Valerie Dennis, Director of ...

The Centers for Medicare & Medicaid Services (CMS) is moving steadily toward the use of FHIR-based digital quality measures (dQMs). CMS believes dQMs will enable a more dynamic, interoperable, and ...

1-Year Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate High Patient Survival with Low Morbidity 2-Year Data from the AMDS PERSEVERE IDE Trial Further Demonstrate the Persistent Clinical ...

Our CVIS (Cardiovascular Information Management System) is a unique software solution that empowers you to improve the clinical and financial performance of your cardiology department. Clinical ...

New York, New York--(Newsfile Corp. - February 2, 2026) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today ...

This codebase contains productionizable and safety certifiable code for an open-source ADAS and Full Self Driving system that can power safe autonomous driving around the world. It is designed to be ...